PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 7.32

Change

-0.04 (-0.54)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+0.89 (+3.01%)

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le..

+23.68 (+3.69%)

USD 7.96B
QLD ProShares Ultra QQQ

+3.06 (+2.70%)

USD 7.84B
SSO ProShares Ultra S&P500

+2.02 (+2.12%)

USD 5.60B
UPRO ProShares UltraPro S&P500

+2.97 (+3.19%)

USD 4.27B
TECL Direxion Daily Technology Bull..

+2.90 (+2.97%)

USD 3.43B
YINN Direxion Daily FTSE China Bull..

+0.97 (+3.37%)

USD 1.61B
USD ProShares Ultra Semiconductors

+1.40 (+2.02%)

USD 1.16B
UDOW ProShares UltraPro Dow30

+2.36 (+2.43%)

USD 0.91B
LABU Direxion Daily S&P Biotech Bul..

+0.18 (+0.19%)

USD 0.82B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.55% 20% F 24% F
Dividend Return 1.01% 50% F 15% F
Total Return -4.54% 20% F 20% F
Trailing 12 Months  
Capital Gain -3.94% 25% F 26% F
Dividend Return 1.02% 50% F 15% F
Total Return -2.91% 25% F 22% F
Trailing 5 Years  
Capital Gain -72.29% 17% F 5% F
Dividend Return 1.06% 16% F 3% F
Total Return -71.23% 17% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 57.84% 81% B- 94% A
Dividend Return 58.39% 81% B- 94% A
Total Return 0.55% 38% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 392.89% 15% F 3% F
Risk Adjusted Return 14.86% 25% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.